SaaS Revenue Health Check

Is your SaaS revenue healthy?

Growth quality diagnosis: strengths, risks, and what to fix next.

Quick answer

Is your SaaS revenue healthy? Enter MRR growth, churn, expansion, and concentration. Get strengths, risks, and actions — a business diagnosis, not a vanity score. Free, no account.

Try it now

Sample: MRR growing while churn rises and expansion thins.

Enter MRR growth, churn, expansion, and concentration. You get a business diagnosis (strengths, risks, actions), not a vanity score.

Example output

Revenue is growing, but growth quality is weakening because churn is elevated.

Strength: MRR up. Risks: churn ~5.5%, thin expansion vs new, concentration. Action: protect retention and expansion.

#1

Growth quality weakening

MRR up while churn eats compounding.

#2

Expansion thin vs new MRR

Acquisition is carrying growth.

#3

Customer concentration

Top account share is a predictability risk.

Connect Stripe for ongoing revenue monitoring in your weekly Guide.

How it works

01

Enter MRR growth and churn

Growth % alone is not health.

02

Add expansion and concentration

Composition shows sustainability.

03

Connect Stripe to monitor

Bridge, failures, and concentration weekly.

Related diagnosis

About this tool

What is SaaS revenue health?

Revenue health is whether growth is sustainable: MRR growth plus churn, expansion, concentration, and predictability. Rising MRR with rising churn is not healthy.

What healthy SaaS metrics should I track?

Track MRR growth, churn (and lost MRR), expansion vs new, failed payments, and whether one customer dominates revenue. Composition matters more than a single growth %.

Is this a health score out of 100?

No. FlarePath returns a business diagnosis: strengths, risks, and recommended actions from the numbers you enter.

How is this different from the Growth Health Check?

Growth Health Check ranks acquisition vs conversion vs retention bottlenecks. This page owns Stripe revenue composition quality: expansion, churn, and concentration under MRR growth.